Xtx Topco LTD Enanta Pharmaceuticals Inc Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$10.08 - $17.46 $17,025 - $29,489	-1,689 Reduced 10.58%	14,282 $249,000
Q4 2023 Feb 13, 2024	SELL	$8.18 - $10.78 $92,033 - $121,285	-11,251 Reduced 41.33%	15,971 $150,000
Q3 2023 Nov 13, 2023	BUY	$11.09 - $22.13 $170,564 - $340,359	15,380 Added 129.88%	27,222 $304,000
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $244,892 - $471,903	11,842 New	11,842 $253,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.